Full Press Release Details
Alterity Therapeutics Limited (ASX: ATH) - Trading
Trading in the securities of Alterity
Therapeutics Limited ( ATH') will be halted at the request of ATH, pending the release of an announcement by ATH.
Unless ASX decides otherwise, the securities will remain
in trading halt until the earlier of:
ATH's request for a trading halt is attached below
for the information of the market.
| 4 September 2025 | Market Announcement 1/1 | |
| ASX Limited | ASX Customer Service Centre 131 279 | asx.com.au |
By email: melissa.kostopoulos@asx.com.au
Adviser, Listings Compliance (Melbourne) ASX Limited
Request for a trading halt
Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) (the
Company), requests that the Company's securities be placed into a trading halt with immediate effect.
For the purposes of Listing Rule 17.1, the Company provides
the following information:
Please contact us should you have any questions.
| /s/ Abby Macnish Niven | |
| Abby Macnish Niven | |
| Company Secretary |
For and on behalf of the Board of Alterity Therapeutics
Alterity Therapeutics Limited
Suite 4, Level 14, 350 Collins Street, Melbourne,
T: +61 (0)3 9349 4906 | www.alteritytherapeutics.com